Lim, S., Mithraprabhu, S., Reynolds, J., Janowski, W., Horvath, N., Quach, H., Campbell, P., McCaughan, G., Kim, Y. J., Suarez, T. P., Lee, S., Wong, P., Nina, B., Meet, P., Le, K., Spencer, A. (2025). An immune-therapeutic salvage strategy for ‘functional’ high-risk (FHR) multiple myeloma (MM) incorporating iberdomide, isatuximab, and dexamethasone – the IBIS study amarc 20-01.. Blood. https://doi.org/10.1182/blood-2025-5841